trending Market Intelligence /marketintelligence/en/news-insights/trending/bXRitJwwbb3xwq8Dn4ImZg2 content esgSubNav
In This List

Cancer Genetics enters hereditary breast, ovarian cancer testing market

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Cancer Genetics enters hereditary breast, ovarian cancer testing market

Cancer Genetics Inc. is entering the hereditary breast and ovarian cancer diagnostics market with the launch of a focused genomic panel to detect such cancers in the human body.

The panel, termed Focus::HERSite, will initially focus on analyzing the 16 most common genes associated with the cancers.

The company estimates that the U.S. market for hereditary breast and ovarian cancer testing is approximately $2.5 billion today and growing at 7% annually.